Bio-Path Holdings is a biotechnology company developing targeted DNA therapeutics for blood cancers and solid tumors. The company's lead candidate is prexigebersen (Liposomal Grb2 Antisense), formerly BP1001, for the treatment of acute myeloid leukemia (AML).

---

Other topics

1. Facebook Zuckerberg
2. Blue-chip
3. 
   Spotify
4. Daily bar reversal
5. 
   Leverage
6. 
   Crypto
7. 
   Tesla
8. Grubhub Company
9. Scalping
10. 
    Presidents day
11. Charlie Munger
12. 
    Mark Zuckerberg
13. Pepsico
14. Roblox
15. ConAgra Foods Inc